FLT3LG expression and NK cell abundance in the tumor are correlated with increased cDC1 levels, better overall survival, and increased responses to anti-PD-1 immunotherapy in metastatic melanoma patients (17). This evidence concerns the gene FLT3LG and neoplasm.